Metastatic Cancer

Showing NaN - NaN of 43

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

HER2-positive Breast Cancer, Metastatic Cancer, Metastatic Breast Cancer Trial in Chicago, Minneapolis (ALX148, Fam-Trastuzumab

Recruiting
  • HER2-positive Breast Cancer
  • +17 more
  • ALX148
  • Fam-Trastuzumab Deruxtecan-Nxki
  • Chicago, Illinois
  • +1 more
May 19, 2023

Metastatic Cancer, Solid Tumors, Advanced Cancer Trial in United States (ASP9801, Pembrolizumab)

Recruiting
  • Metastatic Cancer
  • +2 more
  • ASP9801
  • Pembrolizumab
  • Birmingham, Alabama
  • +26 more
Jan 6, 2023

Recurrent Cancer, Metastatic Cancer, Advanced Malignancies Trial (INCAGN01876, retifanlimab)

Recruiting
  • Recurrent Cancer
  • +3 more
  • INCAGN01876
  • retifanlimab
  • Birmingham, Alabama
  • +17 more
Dec 13, 2022

Metastatic Cancer, Solid Tumor Trial in Worldwide (Sym021, Sym022, Sym023)

Active, not recruiting
  • Metastatic Cancer
  • Solid Tumor
  • Aurora, Colorado
  • +17 more
Sep 8, 2022

Urothelial Carcinoma, Urothelial Carcinoma Bladder, Bladder Cancer Trial in United States (IK-175, IK-175 and nivolumab)

Recruiting
  • Urothelial Carcinoma
  • +20 more
  • Gilbert, Arizona
  • +9 more
Feb 3, 2022

Metastatic Cancer Trial in Chicago, Madison (Nivolumab Standard, Pembrolizumab Standard, Nivolumab Extended)

Recruiting
  • Metastatic Cancer
  • Nivolumab Standard
  • +3 more
  • Chicago, Illinois
  • +1 more
Dec 23, 2021

Advanced Cancer, Metastatic Cancer, Malignant Neoplastic Disease Trial in United States (MRTX849, TNO155)

Active, not recruiting
  • Advanced Cancer
  • +2 more
  • Los Angeles, California
  • +11 more
Nov 12, 2021

Metastatic Cancer, Prostate Cancer Trial in United States (atrasentan HCl, docetaxel, prednisone)

Completed
  • Metastatic Cancer
  • Prostate Cancer
  • atrasentan hydrochloride
  • +3 more
  • Mobile, Alabama
  • +553 more
Oct 8, 2021

Brain and CNS Tumors, Chronic Myeloproliferative Disorders, Leukemia Trial in Chicago (Pemetrexed)

Completed
  • Brain and Central Nervous System Tumors
  • +10 more
  • Chicago, Illinois
    Robert H. Lurie Comprehensive Cancer Center at Northwestern Univ
Sep 3, 2021

Optimizing Y90 Therapy for Radiation Lobectomy

Recruiting
  • HCC
  • +4 more
  • Y90 radioembolization
  • Chicago, Illinois
    Northwestern University
Aug 27, 2021

Solid Tumor, Advanced Cancer, Metastatic Cancer Trial in Los Angeles, Chicago, Morristown (Q702)

Recruiting
  • Solid Tumor
  • +2 more
  • Los Angeles, California
  • +3 more
Jul 29, 2021

Metastatic Cancer, Melanoma, Gastric Cancer Trial in United States (VE800, Nivolumab, Vancomycin Oral Capsule)

Active, not recruiting
  • Metastatic Cancer
  • +4 more
  • VE800
  • +2 more
  • Scottsdale, Arizona
  • +17 more
Jun 22, 2021

Metastatic Cancer, Pain Trial in Canada, Israel, United States (External beam radiation therapy, Radiosurgery/SBRT)

Completed
  • Metastatic Cancer
  • Pain
  • External beam radiation therapy
  • Radiosurgery/SBRT
  • Aurora, Colorado
  • +37 more
Apr 23, 2021

Colorectal Cancer, Metastatic Cancer Trial in United States (FOLFIRI regimen, cisplatin, doxorubicin HCl)

Terminated
  • Colorectal Cancer
  • Metastatic Cancer
  • FOLFIRI regimen
  • +6 more
  • Tucson, Arizona
  • +8 more
Nov 30, 2020

Cognitive/Functional Effects, Metastatic Cancer, Radiation Toxicity Trial in Canada, United States (management of therapy

Completed
  • Cognitive/Functional Effects
  • +2 more
  • management of therapy complications
  • quality-of-life assessment
  • Birmingham, Alabama
  • +240 more
Oct 21, 2020

Metastatic Cancer, Radiation Toxicity, Solid Tumor Trial in Canada, United States (therapeutic melatonin, radiation therapy)

Completed
  • Metastatic Cancer
  • +2 more
  • therapeutic melatonin
  • radiation therapy
  • Birmingham, Alabama
  • +233 more
Oct 21, 2020

Metastatic Cancer, Pain Trial in United States (pain therapy, radiofrequency ablation)

Completed
  • Metastatic Cancer
  • Pain
  • pain therapy
  • radiofrequency ablation
  • Chicago, Illinois
  • +5 more
Aug 11, 2020

Metastatic Cancer, Prostate Cancer Trial in Canada, United States (drug, other, dietary supplement)

Completed
  • Metastatic Cancer
  • Prostate Cancer
  • zoledronic acid
  • +5 more
  • Mobile, Alabama
  • +240 more
Apr 28, 2020

Brain and CNS Tumors, Lymphoma, Metastatic Cancer Trial in Chicago (pemetrexed)

Active, not recruiting
  • Brain and Central Nervous System Tumors
  • +2 more
  • Chicago, Illinois
  • +1 more
Mar 4, 2020

Metastatic Cancer, Solid Tumor Trial in United States (bevacizumab, quality-of-life assessment)

Completed
  • Metastatic Cancer
  • Unspecified Adult Solid Tumor, Protocol Specific
  • bevacizumab
  • quality-of-life assessment
  • Chicago, Illinois
  • +3 more
Sep 4, 2019

Liver Cancer, Metastatic Cancer Trial in Chicago (capecitabine, yttrium Y 90 glass microspheres)

Completed
  • Liver Cancer
  • Metastatic Cancer
  • Chicago, Illinois
    Northwestern University
Sep 5, 2019

S0702: Osteonecrosis of Jaw in Cancer Receiving Zoledronic Acid

Completed
  • Breast Cancer
  • +6 more
  • assessment of therapy complications
  • Anniston, Alabama
  • +452 more
Jul 3, 2019

Cognitive/Functional Effects, Metastatic Cancer, Solid Tumor Trial in Canada, United States (intensity-modulated radiation

Completed
  • Cognitive/Functional Effects
  • +2 more
  • intensity-modulated radiation therapy
  • Birmingham, Alabama
  • +62 more
Sep 25, 2017